Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
71.83
-0.17 (-0.24%)
At close: Aug 15, 2025, 2:56 PM
Corcept Therapeutics Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
141
Upside
96.31
Ratings History
| Analyst | Firm | Rating | Action | Price Target | Upside | Date |
| Canaccord Genuity | Buy | Maintains | 142 137 | 90.74% | Aug 1, 2025 | |
| Piper Sandler | Buy | Maintains | 131 121 | 68.47% | Aug 1, 2025 | |
| HC Wainwright & Co. | Buy | Maintains | 150 145 | 101.88% | May 6, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.